Literature DB >> 12708554

Congenital and acquired brain injury. 4. New frontiers: neuroimaging, neuroprotective agents, cognitive-enhancing agents, new technology, and complementary medicine.

Jacinta M McEligott1, Brian D Greenwald, Thomas K Watanabe.   

Abstract

UNLABELLED: This self-directed learning module explores the clinical application of new and evolving research frontiers in the field of neuroimaging, neuroprotective agents, and cognition-enhancing medications as applied to patients with brain injury. The current and potential clinical applications of robotic technology, virtual reality, and telemedicine in the field of physical medicine and rehabilitation is explored. The evidence to support a growing interest in and application of complementary medicine techniques in brain injury and other disorders is reviewed. OVERALL ARTICLE
OBJECTIVES: (a) To explore the current research and potential clinical applications of medical and technologic advances in neuroprotective agents, cognition-enhancing agents, neuroimaging, virtual reality, robotics, and telemedicine as applicable to brain injury and (b) to identify the evidence to support an expanding use of complementary medicine in brain injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12708554     DOI: 10.1053/apmr.2003.50047

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  1 in total

1.  Reexamining medication adherence in black patients with hypertension through the lens of the social determinants of health.

Authors:  Antoinette M Schoenthaler
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-09-24       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.